BIOTECHNOLOGY VALUE FUND L P - 31 Dec 2024 SCHEDULE 13G/A Report for Ikena Oncology, Inc. Common Stock, par value $0.001 per share (IKNA)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
Ikena Oncology, Inc. Common Stock, par value $0.001 per share
Symbol
IKNA
Shares outstanding
48,271,855 shares
Disclosed Ownership
4,006,564 shares
Ownership
8.3%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 16:22:09 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 4.3% 2,066,854 0 2,066,854 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 4.3% 2,066,854 0 2,066,854 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 3.5% 1,669,108 0 1,669,108 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 3.5% 1,669,108 0 1,669,108 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.4% 208,765 0 208,765 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.4% 208,765 0 208,765 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 7.7% 3,735,962 0 3,735,962 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 8.3% 4,006,564 0 4,006,564 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 8.3% 4,006,564 0 4,006,564 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 8.3% 4,006,564 0 4,006,564 /s/ Mark N. Lampert Mark N. Lampert